TGen and HonorHealth initiate COVID-19 combination therapy
The HonorHealth Research Institute and HonorHealth announced today the successful enrollment on a novel combination of atovaquone and azithromycin in patients with moderate-to-severe COVID-19 infection. The clinical trial, conducted in…
![](https://azbigmedia.com/wp-content/uploads/2020/05/covid-19-vaccine-300x200.jpg)